Are pelvic phleboliths dangerous?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pelvic Phleboliths Are Not Dangerous

Pelvic phleboliths are benign calcified venous structures that pose no threat to health and require no treatment. They are extremely common incidental findings on imaging studies and are generally considered harmless 1, 2.

What Are Pelvic Phleboliths?

  • Phleboliths are calcified thrombi within pelvic veins that appear as small, rounded calcifications on imaging studies 2.
  • Histologically, they consist of calcified laminated fibrous tissue with a surface layer continuous with vein endothelium 2.
  • Prevalence in adults ranges from 38.9% to 48%, making them an extremely common finding 2.
  • They are more frequently seen in adults over age 40 and affect both genders equally 2.

Clinical Significance

No Direct Health Risks

  • Phleboliths themselves cause no symptoms and have no adverse health consequences in the vast majority of cases 1, 2.
  • They are typically discovered incidentally during imaging performed for other reasons 3.

Rare Associations

While generally harmless, the medical literature documents extremely rare associations:

  • Two isolated case reports from 1986 described phleboliths associated with thrombosis, though causation was not established 1.
  • One case report from 2023 described a pregnant patient with stroke attributed to paradoxical embolization of a pelvic phlebolith through a patent foramen ovale 4. This represents an extraordinarily rare event related to pregnancy-specific hemodynamic changes.
  • Phleboliths may be associated with pelvic masses in multiparous females, diverticulitis, or vascular abnormalities, but these are associations rather than causative relationships 5, 2.

Primary Clinical Concern: Distinguishing from Ureteral Stones

The main clinical relevance of phleboliths is avoiding misdiagnosis as ureteral calculi when evaluating patients for kidney stones 3.

Imaging Features to Distinguish Phleboliths from Stones

On CT imaging, phleboliths can be differentiated by:

  • Central lucency (8%-60% sensitivity, 100% specificity for phlebolith) 2
  • Rounded shape (91% positive predictive value for phlebolith) 2
  • Comet-tail sign (21%-65% sensitivity, 100% specificity for phlebolith) 2
  • Lower Hounsfield units (160-350 HU for phleboliths vs higher for stones) 2

Conversely, ureteral stones show:

  • Soft tissue rim sign (50%-77% sensitivity, 92%-100% specificity for stone) 3
  • Geometric shape (100% positive predictive value for stone) 3

When Imaging Is Inconclusive

If CT without contrast is inconclusive for differentiating phlebolith from stone, CT with IV contrast or CT urography can confirm ureteral location of a calculus and distinguish it from adjacent phleboliths or vascular calcifications 3.

Bottom Line

No treatment or follow-up is needed for pelvic phleboliths. They represent a normal variant of aging and venous calcification with no impact on morbidity, mortality, or quality of life 1, 2. The only clinical action required is accurate identification to avoid unnecessary interventions for suspected urolithiasis.

Related Questions

What are the possible causes of my small testicular size and what evaluation should I undergo?
What are the differential diagnoses for changes in the breast areola?
In a 35-year-old man with progressive shortness of breath, mild wheezing, sputum production, a modest smoking history, a family history of early‑onset lung and liver disease, and an obstructive pattern on spirometry, which finding is most likely present in the lower lung lobes?
In a 13-year-old female with lower abdominal (hypogastric) pain, fever, and a preference for the decubitus (side‑lying) position, what are the possible differential diagnoses?
Should a 13-year-old patient requesting breast augmentation undergo the procedure, and what is the appropriate management if it should not be performed?
What is the appropriate management of typhlitis in a neutropenic patient?
What is the recommended vitamin D3 dosing regimen, including loading and maintenance doses, for a patient with suspected deficiency (oral, PEG tube, or injectable options) and how should serum calcium and 25‑hydroxy‑vitamin D be monitored?
In a patient over 60 years old, how frequently should basic labs (complete blood count, comprehensive metabolic panel, fasting glucose or HbA1c, and lipid profile) be obtained?
Why should mean arterial pressure be maintained at ≥90 mmHg in a postoperative T3‑to‑pelvis posterior spinal fusion patient who has developed new extremity weakness?
Does bisoprolol (beta‑blocker) cause reduced appetite?
What are the possible causes and recommended evaluation and treatment for enlarged papillae on the tongue?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.